Pegylated Interferon Lambda for Covid-19

Abstract

To the Editor: Severe Covid-19 is characterized by interferon-λ deficiency.1 In the TOGETHER trial, Reis et al. (Feb. 9 issue)2 found notable efficacy of a single subcutaneous administration of peg...

Authors

Andreakos E; Tsiodras S

Journal

The New England Journal of Medicine, Vol. 388, No. 22, pp. 2107–2108

Publisher

Massachusetts Medical Society

Publication Date

June 1, 2023

DOI

10.1056/nejmc2303519

ISSN

0028-4793

Associated Experts

Gilmar Reis

Associate Professor (Part-Time), Faculty of Health Sciences

Visit profile

Labels

Pegylated Interferon Lambda for Covid-19

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team